Olaparib is a tablet form medicine which triggers cancer cell death in sufferers’ bodies after surgery and chemotherapy.
Dr Susana Banerjee is a Consultant Medical Oncologist at the Sutton based Royal Marsden.
She explains how the international trial affected the 400 women who took part in it.